Neurogene (NGNE) Prepaid Assets (2013 - 2026)
Neurogene (NGNE) reported Prepaid Assets of $3.6 million for Q1 2026, up 257.57% on a YoY basis from $997000.0 in Q1 2025, and up 29.31% quarter-over-quarter from $2.8 million in Q4 2025.
Neurogene (NGNE) Prepaid Assets (2013 - 2026) Analysis & Trends
Neurogene has reported Prepaid Assets for 10 years, with the latest figure at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 257.57% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (up 257.57% YoY), and the FY2025 full-year result was $2.8 million, down 21.63% from the prior year.
- Prepaid Assets for Q1 2026 stood at $3.6 million, up from $2.8 million in the prior quarter.
- The five-year high for Prepaid Assets was $5.1 million in Q3 2025, with the low at $630000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $2.2 million across 5 years, with a median of $2.0 million in 2022.
- Annual changes were most pronounced in 2022 — Prepaid Assets sank 58.61% — and 2023, when it surged 406.51%.
- Neurogene's Prepaid Assets stood at $630000.0 in 2022, then surged by 406.51% to $3.2 million in 2023, then advanced by 10.25% to $3.5 million in 2024, then decreased by 21.63% to $2.8 million in 2025, then grew by 29.31% to $3.6 million in 2026.
- The last three Prepaid Assets figures came in at $3.6 million (Q1 2026), $2.8 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.57 Mn |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 970,000.00 |
| Mar 31, 2025 | 997,000.00 |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 630,000.00 |
| Sep 30, 2022 | 1.98 Mn |
| Jun 30, 2022 | 2.03 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 3.26 Mn |